Tag: HCV


  • Health Screening Campaign Reaches 3 Rural Communities in Upper West Region

    Health Screening Campaign Reaches 3 Rural Communities in Upper West Region

    Health Screening Campaign Reaches Three Rural Communities in Upper West Region A dedicated health awareness and screening campaign focusing on Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) has expanded its outreach to three rural communities in Jirapa Municipality, located in the Upper West Region. The initiative, led by Sahara…

  • Health Screening Campaign Tests Over 600 in Upper West Communities

    Health Screening Campaign Tests Over 600 in Upper West Communities

    Overview of the Campaign A health awareness and screening campaign focusing on HIV, Hepatitis B (HBV), and Hepatitis C (HCV) has delivered concrete results in the Uppe r West Region of Ghana. The initiative, led by Sahara Advocates and supported by local health authorities, successfully screened over 600 residents across three rural communities in the…

  • DAA Therapy: Persistent HCC Risk in HIV-HCV Coinfection Explained

    DAA Therapy: Persistent HCC Risk in HIV-HCV Coinfection Explained

    Understanding the Context: HIV, HCV, and HCC Hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) coinfection pose unique health challenges. In the past decade, direct-acting antivirals (DAAs) transformed HCV treatment, offering high cure rates and improved liver outcomes. However, even after what appears to be a sustained virologic response or cure, researchers have…

  • DAA Therapy and HCC Risk in HIV-HCV Coinfection: Decline Over Time

    DAA Therapy and HCC Risk in HIV-HCV Coinfection: Decline Over Time

    Overview: HIV, HCV, and the risk of hepatocellular carcinoma Hepatocellular carcinoma (HCC) remains a major concern for people living with HIV who have a history of hepatitis C virus (HCV) infection. Even after successful HCV cure with direct-acting antivirals (DAAs), researchers have observed that the risk of developing HCC does not disappear entirely. This evolving…

  • DAA Therapy Linked to Falling HCC Risk in HIV-HCV Coinfection

    DAA Therapy Linked to Falling HCC Risk in HIV-HCV Coinfection

    Hepatitis C, HIV, and the evolving role of DAAs Direct-acting antivirals (DAAs) have transformed hepatitis C virus (HCV) treatment, offering cure rates that were once unimaginable. For people living with both HIV and HCV, the landscape has been more complex. While DAAs effectively clear the hepatitis C infection, experts have long asked how this virologic…

  • Scotland closes in on WHO hepatitis C elimination target as incidence plunges among PWID

    Scotland closes in on WHO hepatitis C elimination target as incidence plunges among PWID

    Scotland on track for WHO hepatitis C elimination New modelling indicates Scotland is edging closer to the World Health Organization’s (WHO) hepatitis C virus (HCV) elimination target, highlighting a significant decline in new infections among people who inject drugs (PWID). The findings come from one of the longest-running studies of HCV transmission in the country,…

  • Scotland Near WHO Hepatitis C Elimination Target as HCV Incidence Drops Among PWID

    Scotland Near WHO Hepatitis C Elimination Target as HCV Incidence Drops Among PWID

    Scotland closes in on WHO hepatitis C elimination target Scotland is edging closer to the World Health Organization’s hepatitis C virus (HCV) elimination target, buoyed by new modelling that indicates a steep fall in HCV incidence among people who inject drugs (PWID). Public health researchers say the trend reflects sustained investments in harm reduction, increased…